Inhibition of AOC3 reduces leukocyte recruitment [21, 22]; therefore, AOC3 inhibition may improve or stabilise the retinal pathology of NPDR by correcting the underlying hypoxia, ischaemia and oedema [23, 25]. This evidence concerns the gene AOC3 and non-proliferative diabetic retinopathy.